Application 211021
- Type
- ANDA
- Sponsor
- JIANGSU HANSOH PHARM
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ICATIBANT ACETATE | ICATIBANT ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 24201-207 | Icatibant | icatibant | Leucadia Pharmaceuticals | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Leucadia Pharmaceuticals | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Leucadia Pharmaceuticals | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Leucadia Pharmaceuticals | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Hikma Cali Inc. | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Hikma Cali Inc. | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Hikma Cali Inc. | ANDA | Current |
| 24201-207 | Icatibant | icatibant | Hikma Pharmaceuticals USA Inc. | ANDA | Current |